Related Articles
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
Autophagy controls programmed death‑ligand 1 expression on cancer cells (Review)
Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status